Wer bezahlt was und an wen? - dies ist eine zentrale Frage im deutschen Gesundheitswesen. Sie muss beantwortet werden, wenn durch zukünftige Reformen eine dauerhafte Finanzierung gewährleistet werden soll. Die Mittelaufbringung, sei es über Steuern, Sozialversicherungsbeiträge,...

In all four countries health care expenditures grow while the revenue remains at the same level or even shrinks in many cases. Due to medical progress, ageing and many other factors the gap is widening over time. The pay-as-you-go approach is running against limits either with rising employer...

Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...